Annual SG&A:
$501.05M+$238.00K(+0.05%)Summary
- As of today, APLS annual SG&A is $501.05 million, with the most recent change of +$238.00 thousand (+0.05%) on December 31, 2024.
- During the last 3 years, APLS annual SG&A has risen by +$324.28 million (+183.45%).
- APLS annual SG&A is now at all-time high.
Performance
APLS SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$131.14M+$1.79M(+1.39%)Summary
- As of today, APLS quarterly SG&A is $131.14 million, with the most recent change of +$1.79 million (+1.39%) on June 30, 2025.
- Over the past year, APLS quarterly SG&A has increased by +$3.06 million (+2.39%).
- APLS quarterly SG&A is now -9.96% below its all-time high of $145.65 million, reached on September 30, 2023.
Performance
APLS Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$12.33B-$228.17M(-1.89%)Summary
- As of today, APLS TTM SG&A is -$12.33 billion, with the most recent change of -$228.17 million (-1.89%) on June 30, 2025.
- Over the past year, APLS TTM SG&A has dropped by -$12.88 billion (-2362.97%).
- APLS TTM SG&A is now -49994.29% below its all-time high of -$24.62 million.
Performance
APLS TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
APLS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +0.1% | +2.4% | -2363.0% |
| 3Y3 Years | +183.4% | +107.5% | -6216.5% |
| 5Y5 Years | +647.3% | +361.5% | -10000.0% |
APLS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +183.4% | -10.0% | +67.3% | -63.4% | at low |
| 5Y | 5-Year | at high | +647.3% | -10.0% | +254.5% | -284.7% | at low |
| All-Time | All-Time | at high | >+9999.0% | -10.0% | >+9999.0% | >-9999.0% | at low |
APLS Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $131.14M(+1.4%) | $503.95M(+0.6%) |
| Mar 2025 | - | $129.34M(+6.5%) | $500.89M(-0.0%) |
| Dec 2024 | $501.05M(+0.0%) | $121.48M(-0.4%) | $501.05M(-3.9%) |
| Sep 2024 | - | $121.98M(-4.8%) | $521.27M(-4.3%) |
| Jun 2024 | - | $128.08M(-1.1%) | $544.93M(+3.2%) |
| Mar 2024 | - | $129.50M(-8.6%) | $528.23M(+5.5%) |
| Dec 2023 | $500.81M(+80.7%) | $141.70M(-2.7%) | $500.81M(+12.9%) |
| Sep 2023 | - | $145.65M(+30.8%) | $443.48M(+17.9%) |
| Jun 2023 | - | $111.37M(+9.1%) | $376.24M(+14.7%) |
| Mar 2023 | - | $102.09M(+21.0%) | $328.07M(+18.4%) |
| Dec 2022 | $277.16M(+56.8%) | $84.37M(+7.6%) | $277.16M(+18.3%) |
| Sep 2022 | - | $78.41M(+24.1%) | $234.26M(+16.2%) |
| Jun 2022 | - | $63.20M(+23.5%) | $201.62M(+7.6%) |
| Mar 2022 | - | $51.19M(+23.5%) | $187.38M(+6.0%) |
| Dec 2021 | $176.77M(+26.8%) | $41.46M(-9.4%) | $176.77M(-1.7%) |
| Sep 2021 | - | $45.76M(-6.5%) | $179.80M(+5.1%) |
| Jun 2021 | - | $48.97M(+20.7%) | $171.03M(+13.7%) |
| Mar 2021 | - | $40.58M(-8.8%) | $150.48M(+7.9%) |
| Dec 2020 | $139.40M | $44.49M(+20.3%) | $139.40M(+13.9%) |
| Sep 2020 | - | $36.99M(+30.2%) | $122.38M(+17.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $28.41M(-3.7%) | $104.02M(+17.7%) |
| Mar 2020 | - | $29.50M(+7.4%) | $88.38M(+31.8%) |
| Dec 2019 | $67.05M(+196.2%) | $27.47M(+47.5%) | $67.05M(+45.9%) |
| Sep 2019 | - | $18.63M(+45.8%) | $45.97M(+36.8%) |
| Jun 2019 | - | $12.78M(+56.4%) | $33.60M(+25.5%) |
| Mar 2019 | - | $8.17M(+27.8%) | $26.77M(+18.3%) |
| Dec 2018 | $22.64M(+116.4%) | $6.39M(+2.0%) | $22.64M(+7.3%) |
| Sep 2018 | - | $6.27M(+5.3%) | $21.11M(+24.8%) |
| Jun 2018 | - | $5.95M(+47.4%) | $16.91M(+33.4%) |
| Mar 2018 | - | $4.04M(-17.0%) | $12.68M(+21.2%) |
| Dec 2017 | $10.46M(+143.1%) | $4.86M(+134.6%) | $10.46M(+56.4%) |
| Sep 2017 | - | $2.07M(+21.1%) | $6.69M(+19.1%) |
| Jun 2017 | - | $1.71M(-6.1%) | $5.62M(+43.8%) |
| Mar 2017 | - | $1.82M(+67.5%) | $3.91M(+87.3%) |
| Dec 2016 | $4.30M(-32.3%) | $1.09M(+8.7%) | $2.09M(-48.4%) |
| Sep 2016 | - | $1.00M(-67.1%) | $4.04M(-9.3%) |
| Dec 2015 | $6.36M(+118.6%) | $3.04M(+115.3%) | $4.46M(+82.7%) |
| Sep 2015 | - | $1.41M(+37.8%) | $2.44M(+43.8%) |
| Dec 2014 | $2.91M(+70.5%) | $1.03M(+53.1%) | $1.70M(+153.1%) |
| Sep 2014 | - | $669.70K | $669.70K |
| Dec 2013 | $1.71M | - | - |
FAQ
- What is Apellis Pharmaceuticals, Inc. annual SG&A?
- What is the all-time high annual SG&A for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. annual SG&A year-on-year change?
- What is Apellis Pharmaceuticals, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. quarterly SG&A year-on-year change?
- What is Apellis Pharmaceuticals, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. TTM SG&A year-on-year change?
What is Apellis Pharmaceuticals, Inc. annual SG&A?
The current annual SG&A of APLS is $501.05M
What is the all-time high annual SG&A for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high annual SG&A is $501.05M
What is Apellis Pharmaceuticals, Inc. annual SG&A year-on-year change?
Over the past year, APLS annual SG&A has changed by +$238.00K (+0.05%)
What is Apellis Pharmaceuticals, Inc. quarterly SG&A?
The current quarterly SG&A of APLS is $131.14M
What is the all-time high quarterly SG&A for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high quarterly SG&A is $145.65M
What is Apellis Pharmaceuticals, Inc. quarterly SG&A year-on-year change?
Over the past year, APLS quarterly SG&A has changed by +$3.06M (+2.39%)
What is Apellis Pharmaceuticals, Inc. TTM SG&A?
The current TTM SG&A of APLS is -$12.33B
What is the all-time high TTM SG&A for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high TTM SG&A is -$24.62M
What is Apellis Pharmaceuticals, Inc. TTM SG&A year-on-year change?
Over the past year, APLS TTM SG&A has changed by -$12.88B (-2362.97%)